Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Ampullary Adenocarcinoma × Irinotecan × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Colorectal Neoplasms 5 Stomach Neoplasms 3 Colonic Neoplasms 2 Uterine Cervical Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Liver Neoplasms 1 Gallbladder Neoplasms 1 Fruquintinib 1 Esophageal Neoplasms 1 Colorectal Cancer Metastatic 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1 Ampullary Adenocarcinoma 1

Interventions

folfirinox 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Fluorouracil 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06068023 2023-10-05

ADAPTA

Fondazione Poliambulanza Istituto Ospedaliero

Ampullary Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡